NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

Diabetes Mellitus, Non-Insulin-Dependent

Interventions

DRUG

NNC 90-1170

Trial Locations (1)

University of Michigan, Ann Arbor

All Listed Sponsors

lead

National Center for Research Resources (NCRR)

NIH